NATICK, Mass., Sept. 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX - News) today welcomed the results of two studies and an editorial published in today's edition of The New England Journal of Medicine (NEJM), all of which reaffirmed the safety and efficacy of drug-eluting stents.
